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■ SHORT COMMUNICATION ■
Introduction
Radiation therapy is the standard treatment for patients
with FIGO stage IIB to IVA cervical cancer. The risk of
secondary malignancies after radiation therapy remains
controversial. One of the reasons for the uncertainty is
that patients undergoing radiotherapy are often at high
risk of a second cancer because of their lifestyles or
genetic predisposition, which could be more dominant
than the radiation risk [1].
Post-radiation sarcoma is one type of malignancy,
first reported by Beck in the 1920s [2]. In the current clas-
sification, carcinosarcoma is synonymous with malig-
nant mixed müllerian tumor (MMMT). Carcinosarcoma
can arise from the female genital tract, and the endome-
trium is the most common primary site [3]. Moreover,
uterine cervical cancer is one of the more common neo-
plasms in which sarcoma has been reported after radi-
ation therapy [4].
We present a patient with cervical squamous cell
carcinoma FIGO stage IIIB, who had been treated with
pelvic irradiation. However, carcinosarcoma was diag-
nosed 5 years after radiotherapy.
Case Report
A 57-year-old, gravida 6, para 4, woman had never
received hormone therapy after her menopause at 51
years of age. She visited our outpatient department for
the first time due to postmenopausal bleeding. Pelvic
examination revealed a cervical mass with bilateral para-
metrium induration; pathology of cervical biopsy showed
squamous cell carcinoma. After complete survey, the
patient was diagnosed with cervical squamous cell car-
cinoma FIGO stage IIIB. CEA and SCC levels before
treatment were 0.9 U/mL and 0.8 ng/mL, respectively.
Thereafter, the patient received irradiation, including
brachytherapy and teletherapy, for her disease.
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Teletherapy was whole pelvis irradiation using 10 mil-
lion velocity Linac X-ray delivering 220 cGy per day up to
4,400 cGy, and then the field was reduced to the true
pelvis with a total dosage of 1,400cGy in seven fractions,
which was delivered through anteroposterior parallel
opposed field. Brachytherapy to point A was delivered
with intrauterine tandem and vaginal colpostats in the
use of Ir-192, with a total dosage of 2,580 cGy in six
fractions. The patient received regular pelvic examination
and Papanicolaou smear after irradiation. Follow-up
computed tomography (CT) scan 12 months after
irradiation showed tumor regression and no evidence
of tumor recurrence.
However, 60 months after irradiation, routine Papa-
nicolaou smear revealed adenocarcinoma. Ultrasono-
graphy disclosed thickened endometrium, measuring
22 mm, with irregular contour. Dilatation and curet-
tage showed carcinosarcoma of the endometrium. The
patient underwent surgical treatment with total abdomi-
nal hysterectomy, bilateral salpingo-oophorectomy, and
bilateral pelvic lymph node dissection (Figure 1), fol-
lowed by six courses of chemotherapy with cisplatin and
ifosfamide. The pathologic findings of the endometrium,
endocervix and exocervix were all carcinosarcoma, which
was a secondary malignancy with a completely differ-
ent cell type from the primary cervical squamous cell
carcinoma (Figures 2 and 3).
Unfortunately, the cancer recurred over the vaginal
cuff 8 months after surgery. The patient eventually died
due to cancer progression 1 month later.
Discussion
Uterine cervical cancer is one of the most common neo-
plasms in women that require irradiation to the whole
pelvis even after complete cytoreduction. Secondary neo-
plasm due to previous radiation therapy has been
reported sporadically in the literature since the 1980s.
MMMT of the female reproductive system often repre-
sents a highly aggressive neoplasm that is character-
ized by a mixture of malignant epithelial and stromal
elements comprising carcinomatous and sarcomatous
neoplastic cells [5]; the endometrium is usually the
primary site [3]. Nevertheless, endometrial tissue can
persist after radiation therapy for cervical cancer and
undergo neoplastic transformation [6]. Hoffman et al
demonstrated that most post-radiation sarcomas were
carcinosarcomas [7].
The carcinogenic effect caused by irradiation has
been a subject of controversy and debate. Lorigan et al
suggested that for radiation to induce malignant change,
Figure 1. Uterus, bilateral tubes and ovaries: the lesion of
secondary malignancy occupies mainly the endometrial cavity.
Figure 2. Pathologic specimen of cervical squamous cell carci-
noma: invasive nests of moderately differentiated squamous
cell carcinoma are seen (hematoxylin and eosin, 200×).
Figure 3. Pathologic specimen of malignant mixed müllerian
tumor: both spindle cell sarcomatous areas and adenocarci-
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the injury to individual cells must be sufficient to cause
genetic mutation but insufficient to cause cell death; a
situation that apparently arises at the margins of the
radiation field [8]. Boice et al studied the risk of second-
ary malignancies as a consequence of radiation treat-
ment of cervical cancer and reported that very high
dose increased the risk of cancer of the bladder, rec-
tum, vagina, uterine corpus, and bone [9]. Moreover,
according to Strom’s study, the relative risk increased
with time in organs close to and at an intermediate
distance from the cervix, reaching a maximum after 
≥ 30 years of follow-up since treatment [10].
Most histologic types of secondary malignant tumors
tend to have a long latent period and appear late (≥ 10
years after radiotherapy), except for radiation-induced
leukemia [2,10]. Yu reported that 10 cases of second-
ary MMMT occurred within 5–19 years after radiother-
apy for cervical cancer [11]. Based on Hagiwara et al’s
study, the average latent period from initial irradiation
to development of endometrial carcinoma is 13.4 years
[12]. Naturally, the risk of secondary cancer associ-
ated with radiation peaks among long-term survivors
and women irradiated at a relatively younger age [13].
Nevertheless, patients treated by radiotherapy for cer-
vical cancer are usually young and often survive for many
years. However, as for post-irradiated uterine malig-
nancies, delay in diagnosis may occur due to synechiae
or stenosis of the cervix and cervical canal induced by
previous irradiation, which prevent early onset of
symptoms and require more effort to diagnose [12].
Although secondary malignancies induced by irra-
diation usually appear late, at >10 years after treatment,
there is the possibility that it will occur earlier than ex-
pected. In this patient, it took only 5 years for the malig-
nancy to arise. The time interval is relatively shorter.
For patients surviving cervical cancer, follow-up with
regular Papanicolaou smear is the standard manage-
ment. For those who received irradiation, not only long-
term follow-up but also extreme caution is mandatory.
For patients who present with any types of symptoms,
aggressive and immediate investigation, including
sonography and even tissue biopsy, is suggested in
order to detect the possible occult malignancy as early
as possible.
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